ING-Series
Various cardiometabolic and chronic inflammatory conditions
PreclinicalActive
Key Facts
Indication
Various cardiometabolic and chronic inflammatory conditions
Phase
Preclinical
Status
Active
Company
About Innosphera Pharma
First‑in‑class oral GPR84 modulator for IPF with a lipid‑mimetic platform targeting fibrosis and metabolic disease.
View full company profile